azomycin has been researched along with Neuroblastoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chun, S; Kim, HK; Kwon, YD; Oh, JM | 1 |
| Baruchel, S; Kumar, S; Marrano, P; Thorner, P; Wu, B; Zhang, L | 1 |
| Dethloff, LA; Miller, TJ; Phelka, AD; Philbert, MA; Tjalkens, RB | 1 |
3 other study(ies) available for azomycin and Neuroblastoma
| Article | Year |
|---|---|
Synthesis and evaluation of multivalent nitroimidazole-based near-infrared fluorescent agents for neuroblastoma and colon cancer imaging.
Topics: Cell Line, Tumor; Colonic Neoplasms; Fluorescent Dyes; Humans; Infrared Rays; Molecular Structure; Neuroblastoma; Nitroimidazoles; Optical Imaging | 2021 |
Combined Antitumor Therapy with Metronomic Topotecan and Hypoxia-Activated Prodrug, Evofosfamide, in Neuroblastoma and Rhabdomyosarcoma Preclinical Models.
Topics: Activation, Metabolic; Administration, Metronomic; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Hypoxia; Cell Line, Tumor; Cell Proliferation; Drug Synergism; Inhibitory Concentration 50; Mice, Inbred NOD; Mice, SCID; Neuroblastoma; Nitroimidazoles; Phosphoramide Mustards; Prodrugs; Rhabdomyosarcoma; Topotecan; Xenograft Model Antitumor Assays | 2016 |
CI-1010 induced opening of the mitochondrial permeability transition pore precedes oxidative stress and apoptosis in SY5Y neuroblastoma cells.
Topics: Antioxidants; Apoptosis; Brain Neoplasms; Cell Death; Cell Survival; DNA Fragmentation; Flow Cytometry; Humans; In Situ Nick-End Labeling; Membrane Potentials; Microscopy, Electron; Mitochondria; Neuroblastoma; Nitroimidazoles; Oxidative Stress; Permeability; Photoreceptor Cells; Radiation-Sensitizing Agents; Reactive Oxygen Species; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured; Vitamin E | 2003 |